25 episodes

Overdrive is a podcast by Rheumatology Network, a publication of MJH Life Sciences. Every week we talk with healthcare experts on treatments for rheumatic disease, such as rheumatoid arthritis, psoriatic arthritis, gout, juvenile arthritis and other conditions. We also cover musculoskeletal conditions, such as osteoarthritis.

Overdrive by Rheumatology Network Rheumatology Network

    • Science
    • 5.0 • 2 Ratings

Overdrive is a podcast by Rheumatology Network, a publication of MJH Life Sciences. Every week we talk with healthcare experts on treatments for rheumatic disease, such as rheumatoid arthritis, psoriatic arthritis, gout, juvenile arthritis and other conditions. We also cover musculoskeletal conditions, such as osteoarthritis.

    What's Limiting Medical Marijuana Therapy in Rheumatology?

    What's Limiting Medical Marijuana Therapy in Rheumatology?

    Benjamin Nowell, PhD, and Stuart Silverman, MD, FACP, FACR, discuss the recent publication of a new review article, “Cannabis for rheumatic disease pain: A review of current literature.” Investigators discovered that progress in understanding cannabis-based therapies for treating the pain associated with rheumatic disease is hindered due to a lack of standardization of clinical research and current barriers to conducting such research due to federal and state regulations. Nowell is the Director of Patient-Centered Research at CreakyJoints and principal investigator of the ArthritisPower Research Registry. Silverman is a rheumatologist and Clinical Professor of Medicine at Cedars-Sinai Medical Center and UCLA School of Medicine, as well as a faculty member of the UCLA Cannabis Research Initiative.

    • 23 min
    Overdrive Podcast: ArthritisPower Redesign and Research

    Overdrive Podcast: ArthritisPower Redesign and Research

    I sat down with Dr. Benjamin Nowell and David Curtis to chat about the the recent press release that CreakyJoints published addressing updates to their ArthritisPower interface in order to improve the user’s experience, including incorporating patient perspectives. We discuss how the changes will help both patients and rheumatologists alike, recent research, and what we have to look forward to in the near future.

    Dr. Nowell is Director of Patient-Centered Research at the Global Healthy Living Foundation and principal investigator of ArthritisPower and David is the Director of Technology and Data Service at the Global Healthy Living Foundation.

    • 20 min
    Overdrive Update: Guselkumab for Treating Active Psoriatic Arthritis Part 2

    Overdrive Update: Guselkumab for Treating Active Psoriatic Arthritis Part 2

    On this month’s episode, I spoke with Soumya D. Chakravarty, MD, PhD, to discuss the growing body of clinical evidence evaluating joint efficacy, safety and patient-reported outcomes in patients with psoriatic arthritis receiving guselkumab.

    • 14 min
    Efficacy of Guselkumab for Treating Psoriatic Arthritis

    Efficacy of Guselkumab for Treating Psoriatic Arthritis

    Rheumatology Network interviewed Terence Rooney, MD, to discuss the findings of a Network Meta-Analysis that examined the efficacy of guselkumab (TREMFYA) for skin clearance and joint improvements in patients with psoriatic arthritis.

    • 16 min
    Overdrive Podcast: Pain Improvement and Patient-Reported Outcomes in Patients with Psoriatic Arthritis

    Overdrive Podcast: Pain Improvement and Patient-Reported Outcomes in Patients with Psoriatic Arthritis

    Louis Bessette, MD, MSc, discusses his ACR presentation, “Impact of Early Pain Improvement on Patient-reported Outcomes in Patients with Psoriatic Arthritis: Results from a Phase 3 Trial.” Bessette is affiliated with the Center for Osteoporosis and Rheumatology of Quebec. He explains why pain is a largely unmet need in this patient population, the study design, and further research his team plans on tackling in the future.

    • 11 min
    Impact of COVID-19 on Quality of Life of Patients With Rheumatic Disease

    Impact of COVID-19 on Quality of Life of Patients With Rheumatic Disease

    On this month's episode, we interviewed Courtney Wells, PhD, MPH, MSW, to discuss the impact of COVID-19 on the quality of life of patients with rheumatic conditions, focusing on perceived risk and decision making.

    Time Stamps:
    1:04: What first sparked your interest in quality of life during the pandemic for generally underrepresented patients with rheumatic disease?
    2:27: Can you tell me a little bit about the study design and methods used by your team to ascertain quality of life and patient perspectives?
    4:29: What were the key findings of your study?
    6:07: Were you surprised by the results?
    9:22: Were there any strengths or limitations of the study that you’d like to discuss?
    11:00: Is there anything else you’d like our audience to know before we wrap up?

    • 12 min

Customer Reviews

5.0 out of 5
2 Ratings

2 Ratings

Top Podcasts In Science

Hidden Brain
Alie Ward
Bloomberg
Sam Harris
Neil deGrasse Tyson
Andrew Bustamante

You Might Also Like